Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant

Jan 3, 2021 by in INFECTIOUS DISEASE Comments Off on Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant

Basic principles of the infectious disease pretransplant evaluation The pretransplant infectious disease evaluation represents the first step in a long continuum of infection prevention that extends into the posttransplant period….

read more

Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient

Jan 3, 2021 by in INFECTIOUS DISEASE Comments Off on Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient

Infections are one of the most frequent serious complications of hematopoietic stem cell transplantation (HSCT). The risk of infections corresponds to the complex interplay between organ dysfunction or tissue damage,…

read more

The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient

Jan 3, 2021 by in INFECTIOUS DISEASE Comments Off on The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient

Balanced immunosuppression is essential to ensure acceptance of a solid organ transplant and an overall successful patient outcome. The fundamental purpose of immunosuppression is to modulate the immune system’s ability…

read more

Clostridioides difficileinfection

Oct 27, 2020 by in ONCOLOGY Comments Off on Clostridioides difficileinfection

Clostridioides difficile , formerly knowns as Clostridium difficile, is a Gram-positive, anaerobic bacillus, with a spore phase that prolongs survival in the environment. Ingestion of spores that are resistant to…

read more

Gastrointestinal viruses

Oct 27, 2020 by in ONCOLOGY Comments Off on Gastrointestinal viruses

Diarrheal disease is the second most common cause of death in children younger than 5 years worldwide, according to the World Health Organization (WHO). In the United States, viruses are…

read more

Pneumocystispneumonia

Oct 27, 2020 by in ONCOLOGY Comments Off on Pneumocystispneumonia

Epidemiology and risk factors Pneumocystis jirovecii (formerly Pneumocystis carinii ) is an infrequent though potentially deadly cause of fungal pneumonia ( P. jirovecii pneumonia [PJP]) in immunocompromised patients. P. jirovecii…

read more

Nocardiaand actinomyces

Oct 27, 2020 by in ONCOLOGY Comments Off on Nocardiaand actinomyces

Nocardia Epidemiology and risk factors Nocardia species are a heterogeneous group of ubiquitous aerobic, gram-positive filamentous organisms that reside in soil and decaying organic matter and are associated with an…

read more

Toxoplasma gondii

Oct 27, 2020 by in ONCOLOGY Comments Off on Toxoplasma gondii

Epidemiology and risk factors Toxoplasma gondii is a protozoan parasite in the phylum Apicomplexa. It infects humans and almost all warm-blooded animals, including mammals and birds. Transmission of T. gondii…

read more
Get Clinical Tree app for offline access